Inventor · disambiguated record
Hartmut Ney
Also filed as: NEY HARTMUT
12 granted patents·12 pending applications·245 citations·filing 1992–2015
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US7951398B2Pharmaceutical preparation comprising an active dispersed on a matrixNYCOMED GMBH·Filed 2006·Granted May 31, 2011·50 cites·20 claims
- 0289US7175854B2Pharmaceutical preparation comprising an active dispersed on a matrixALTANA PHARMA AG·Filed 2001·Granted Feb 13, 2007·30 cites·14 claims
- 0389US5997903AOral-administration forms of a medicament containing pantoprazolBYK GULDEN LOMBERG CHEM FAB·Filed 1992·Granted Dec 7, 1999·103 cites·11 claims
- 0488US7147869B2Rapidly disintegrating tablet comprising an acid-labile active ingredientALTANA PHARMA AG·Filed 2001·Granted Dec 12, 2006·33 cites·14 claims
- 0586US7951397B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2003·Granted May 31, 2011·13 cites·33 claims
- 0685US8431154B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipientDIETRICH RANGO·Filed 2011·Granted Apr 30, 2013·5 cites·38 claims
- 0767US7402321B2Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazolesNYCOMED GMBH·Filed 2006·Granted Jul 22, 2008·0 cites·30 claims
- 0866US9468598B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientASTRAZENECA AB·Filed 2013·Granted Oct 18, 2016·0 cites·41 claims
- 0965US2014031396A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 1065US2014031397A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 1163US8465767B2Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazolesDIETRICH RANGO·Filed 2008·Granted Jun 18, 2013·0 cites·21 claims
- 1263US2006269600A1Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientALTANA PHARMA AG·Filed 2006·Application pending·0 cites
- 1363US2013131123A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientDIETRICH RANGO·Filed 2013·Application pending·0 cites
- 1460US2015290179A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 1560US2015290180A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 1660US2015290178A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 1759US7041313B1Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazolesALTANA PHARMA AG·Filed 1999·Granted May 9, 2006·11 cites·36 claims
- 1859US2011060016A1Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2010·Application pending·0 cites
- 1951US8703192B2Dosage form containing pantoprazole as active ingredientANSTETT-KLEIN ISABEL·Filed 2009·Granted Apr 22, 2014·0 cites·9 claims
- 2044US8758817B2Dosage form containing (S)-pantoprazole as active ingredientDIETRICH RANGO·Filed 2011·Granted Jun 24, 2014·0 cites·11 claims
- 2143US2006216346A1Dosage form containing (s)-pantoprazole as active ingredientALTANA PHARMA·Filed 2004·Application pending·0 cites
- 2241US2006204568A1Oral pharmaceutical preparation for proton pump antagonistsDIETRICH RANGO·Filed 2004·Application pending·0 cites
- 2331US2008050428A1Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic ExcipientALTANA PHARMA AG·Filed 2005·Application pending·0 cites
- 2426US2008102133A1Oral Pharmaceutical Preparation for Proton Pump AntagonistsBRUECK-SCHEFFLER ANTJE·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →